JURY SELECTION BEGINS IN THE BATTLE IN THE CITY OF BEN FRANKLIN: UNITED STATES OF AMERICA vs. DR. NEIL ANAND, MD, A CASE THAT POTENTIALLY WILL RE-DEFINE MEDICAL PROSECUTIONS:

THE EYES OF BEN
Prosecutorial Collusion and Their Fundamental Flaw in Medical Sciences

NORMAN J CLEMENT RPH., DDS, NORMAN L. CLEMENT PHARM-TECH, MALACHI F. MACKANDAL PHARMD, BELINDA BROWN-PARKER, IN THE SPIRIT OF JOSEPH SOLVO ESQ., INC.T. SPIRIT OF REV. IN THE SPIRIT OF WALTER R. CLEMENT BS., MS, MBA. HARVEY JENKINS MD, PH.D., IN THE SPIRIT OF C.T. VIVIAN, JELANI ZIMBABWE CLEMENT, BS., MBA., IN THE SPIRIT OF THE HON. PATRICE LUMUMBA, IN THE SPIRIT OF ERLIN CLEMENT SR., EVELYN J. CLEMENT, WALTER F. WRENN III., MD., JULIE KILLINGSWORTH, RENEE BLARE, RPH, DR. TERENCE SASAKI, MD LESLY POMPY MD., CHRISTOPHER RUSSO, MD., NANCY SEEFELDT, WILLIE GUINYARD BS., JOSEPH WEBSTER MD., MBA, BEVERLY C. PRINCE MD., FACS., NEIL ARNAND, MD., RICHARD KAUL, MD., IN THE SPIRIT OF LEROY BAYLOR, JAY K. JOSHI MD., MBA, AISHA GARDNER, ADRIENNE EDMUNDSON, ESTER HYATT PH.D., WALTER L. SMITH BS., IN THE SPIRIT OF BRAHM FISHER ESQ., MICHELE ALEXANDER MD., CUDJOE WILDING BS, MARTIN NJOKU, BS., RPH., IN THE SPIRIT OF DEBRA LYNN SHEPHERD, BERES E. MUSCHETT, STRATEGIC ADVISORS

FINE POINTS OF DISCUSSIONS THAT WILL OCCUR IN THIS TRIAL

According to  John D. Lilly, M.B.A., D.O., practices family medicine in Springfield, MO. (Contact: johnlilly97@gmail.com)

“Not all opioids are identical in abuse potential and likely lethality, yet government statistics group causes of death in a way that obscures the importance of identifying specific agents involved in deadly overdoses. 

https://command.md/team/dr-john-lilly/


Opiates include prescription pain medications and heroin, which is included because its metabolite cannot always be distinguished from the metabolites of other opiates.

Flawed Science Argument: Explain Dr. Anand’s contention that the DEA’s reliance on concepts like Morphine Milligram Equivalents (MME) as a strict guideline for prescribing demonstrates a lack of understanding of medical science and individual patient needs.

THE STATE OF ILLINOIS OUTLAWS THE USE OF “MORPHINE MILLIGRAM EQUIVALENT” AS A GUIDELINE FOR PRESCRIBING NARCOTIC ANALGESICS FOR PAIN

Through the persistent advocacy of BobSheerin, Nancy Seefedlt, Pharmacist Steve Ariens, and Atty Kat Hatz of The American Diability Foundation, the State ofIllinois has signed into law a Ban on the usage of Morphine Milligram Equivalent (MME)

nancy see
FROM PHARMACIST STEVE

from the offices of pharmacist steve

“It took the CDC THREE YEARS to admit their mistakes, but here we are SIX YEARS later. Has anyone seen any significant movement to undo the harm caused by those 2016 guidelines? Does this suggest that those behind the OPIOID PROHIBITION AGENDA have no intention of actually IGNORING THE FACTS that they are causing suffering and harm to untold tens of millions of our citizens?”

nancy see

UNITED STATES OF AMERICA

VS.

ANAND, MD, ET AL.

Legitimate Medical Purpose: Define this term in the context of controlled substance prescriptions and the legal requirement for a prescription to be valid. Note the disagreement between the DEA and Dr. Muhamed Aly Rifia, MD., Dr Rajendra Bothra, MD., Pronto Pharmacy LLC, and Dr. Christopher Russo, MD., regarding its interpretation.

THE REPROBATES, A CULTURE OF CORRUPTION

But that’s not all because “The drugs acquired through legitimate prescriptions cannot be differentiated from diverted prescription medications or illicit drugs because information on the source is unavailable.”

HOW THE WAR ON DRUGS COMES TO YOUR DOCTORS OFFICE CRIMINALIZATION OF MEDICINE

This means we cannot know whether misused drugs originate from the theft of warehouses or trucks or those prescribed by physicians.

Indeed, the claim that “pill mills” are responsible for drug addiction, deaths, and morbidity is fake science.

These so-called studies have many problems, such as using only six states to represent the entire country and describing common myths.

”According to the 2005 Libby Report,

“..To target doctors, investigators look for “red flags” that indicate potentially criminal behavior. These red flags are generally circumstantial evidence found during standard criminal investigative procedures.

Dr. Terry Sasaki remains convicted of a crime he never committed & the U.S. Government knows he didn’t commit.
“Unraveling The Opioid Crisis: A Multifaceted Geopolitical Analysis”.

“Red Flags”: Explain how the DEA has utilized the concept of “red flags” (indicators of potential diversion or abuse) to assess a pharmacy’s corresponding responsibility. Understand Pronto Pharmacy’s argument against the DEA’s reliance on unresolved “red flags” alone.

RED FLAG OF DEA-DOJ STUPIDITY

The problem with red flags is that what may appear to be evidence of criminal behavior to an investigator without medical training is often perfectly consistent with legitimate medical practice, particularly in a dynamic field like pain management.

Knowing Standard: Understand the significance of “knowingly” in 21 C.F.R. § 1306.04(a) regarding a pharmacist’s liability for filling an illegitimate prescription. Contrast this with the DEA’s focus on unresolved “red flags.”

Separation of Powers: Consider the argument that the DEA’s actions constitute an overreach into medicine, an area traditionally regulated by states and medical boards, potentially violating the separation of powers.

Eighth Amendment: Understand Pronto Pharmacy, Suntree Pharmacy et al. argue that requiring pharmacists to operate beyond their licensing and training by refusing to fill prescriptions for legitimate medical purposes constitutes cruel and unusual punishment.

THE DEA WITCH HUNT
“DEA on Legitimate Medical Purpose of Prescriptions.”

Overdose deaths have increased because overreach by the DEA on doctors has caused patients with poor pain control to resort to street drugs, which cause five times more deaths than pills.[16] 

AI, Pain Medication, and the Opioid Crisis: A Study Guide

I. Key Concepts and Summary

This article from Marketplace Tech discusses the increasing use of artificial intelligence (AI) in monitoring and influencing the prescription of pain medication, particularly opioids. The goal is to combat the opioid crisis by identifying potential misuse and preventing overdoses; risk ratings are used to assess patient’s risk based on their prescription history.

These systems draw data from state-run Prescription Drug Monitoring Programs (PDMPs).

While these AI systems aim to reduce opioid-related harm, they also raise concerns about bias, accuracy, lack of transparency, and potential harm to patients with legitimate pain management needs.

AMERICAN AGONY THE OPIOID WARHelen Borel, RN, Ph.d

Some patients have reported being denied necessary medication or stigmatized due to their scores. Some doctors also report being unfairly targeted, even losing licenses. The article highlights the need for independent testing, transparency, and careful consideration of AI’s ethical and practical implications in healthcare decision-making.

II. Quiz: Short Answer Questions

  1. What is a Narx Score, and what is it used for?
  2. What are Prescription Drug Monitoring Programs (PDMPs), and how are they used?
  3. According to the article, what are some potential benefits of using AI to monitor opioid prescriptions?
  4. What are some concerns or criticisms raised about the use of AI in opioid prescription monitoring?
  5. How might AI-driven prescription monitoring affect patients with chronic pain?
  6. What steps has the CDC taken to address the use of PDMP programs?
  7. Besides NarxCare, what other uses of AI in the opioid crisis are mentioned in the article?
  8. What does the American Medical Association (AMA) say about the use of unknown or unreviewed algorithms when prescribing pain medication?
  9. What data points are taken into consideration when Bamboo Health (formerly Appriss Health) generates an “Overdose Risk Score?”
  10. What steps does Qlarant take to identify questionable behavior among doctors prescribing controlled substances?

III. Quiz: Answer Key

Tools like Narx Scores and algorithm-generated overdose risk ratings are used to assess patient’s risk based on their prescription history. These systems draw data from state-run Prescription Drug Monitoring Programs (PDMPs).

PAIN MANAGE IS THE NEW SUICIDE PREVENTION

While these AI systems aim to reduce opioid-related harm, they also raise concerns about bias, accuracy, lack of transparency, and potential damage to patients with legitimate pain management needs.

Some patients have reported being denied necessary medication or stigmatized due to their scores. Some doctors also report being unfairly targeted, even losing licenses.

The article highlights the need for independent testing, transparency, and careful consideration of AI’s ethical and practical implications in healthcare decision-making.

III. Quiz: Answer Key

  1. A Narx Score is a tool used to help medical providers review controlled substance prescriptions. It influences and can limit the prescribing of painkillers, similar to a credit score influencing the terms of a loan. Bamboo Health produces it on its NarxCare platform.
  2. Prescription Drug Monitoring Programs (PDMPs) are electronic databases used by states to track prescriptions for controlled substances. This data can be fed into platforms such as NarxCare to help medical professionals make decisions.
  3. Potential benefits include identifying patterns of potential problems involving patients and physicians, reducing opioid prescriptions, speeding up the development of addiction medications, and reducing harm from the opioid crisis.
  4. Concerns include bias, accuracy, lack of transparency, insufficient independent testing, potential for harm to patients, stigmatization, and unfair targeting of doctors.
  5. AI-driven prescription monitoring may lead to patients being denied necessary medication, stigmatized, undertreated for pain, or forced to seek medication from illicit sources.
  6. The CDC advises clinicians to consult PDMP data before prescribing pain medications but warns that “special attention should be paid to ensure that PDMP information is not used in a way that is harmful to patients.”
  7. AI is also being used to predict opioid overdose deaths in communities via social media posts and to speed up the development of medications for opioid addiction.
  8. The AMA states that “These unknown and unreviewed algorithms have resulted in physicians having their prescribing privileges immediately suspended without due process or review by a state licensing board — often harming patients in pain because of delays and denials of care.”
  9. NarxCare’s algorithm-generated “Overdose Risk Score” draws on a patient’s medication information from PDMPs — such as the number of doctors writing prescriptions, the number of pharmacies used, and drug dosage.
  10. Qlarant algorithms can “analyze a wide variety of data sources,” including court records, insurance claims, drug monitoring data, property records, and incarceration data to flag providers.
@bobsheerin.apdf

#stitch #spoonies #duet #APDF @American Pain & Disability FDN @SnarkilyAndrew60 @The Kat In The Hatz @Shirl

♬ original sound – Bob Sheerin

The tremendous amount of narcotics being stolen or lost, NOT the prescriptions written by doctors.[17] Only 22-35% of those misusing pain meds receive them from their doctors & only 1-8% of those who take pills for chronic pain become addicted.[18] 

Fentanyl has been responsible for many deaths for many years[19], but the DEA has dragged its feet addressing it because each time abuse & deaths increase, so do their budget, seizures, & forfeitures.  

To this day, the DoJ has done little to curb the theft, loss, & unaccountability of manufacturers & distributors of narcotics while pointing the finger at doctors.  

Joe Rannazzisi, seen here in September, ran the DEA’s division responsible for regulating the drug industry and led a decade-long campaign of aggressive enforcement until he was forced out of the agency in 2015. MUST CREDIT: Washington Post photo by Jahi Chikwendiu
“RANNAZZI U-TUBES TIME LINE_The Opioid Epidemic_ Imports, Smuggling, and Distribution”.

This means that EVERYONE who died of heroin is assumed & included in statistics for drug misuse death that SAMSHA & the DEA claim was due to prescriptions written by physicians.

OVERDOSE DEATHS INCREASED WHILE PRESCRIPTION NARCOTIC PRESCRIBING VOLUME DROPPED

Ronald W. Chapman II, Esq., LL.M, masters communication and persuasion, blending classical training in philosophy, rhetoric, and behavioral economics with modern expertise in law and strategy. With a law degree and a Master of Laws (LL.M) from Loyola University Chicago, Chapman has built a distinguished career as a federal criminal defense attorney, achieving an extraordinary 139 federal counts acquitted in high-stakes cases.




VS.

AUSA P.J. KOOB, MD

Drawing on his courtroom triumphs, scholarly foundation, military experience with the United States Marine Corps, and passion for effective communication, Chapman offers readers the tools to make their ideas stick in a meaningful and fulfilling way.

“Unraveling The Opioid Crisis_ A Multifaceted Geopolitical Analysis”.

Whether in the courtroom or through his writing, Chapman is dedicated to helping others navigate the complexities of modern persuasion with authenticity and skill.

Chapman’s unique approach to persuasion is rooted in his deep understanding of human behavior and his ability to integrate timeless principles of logic and rhetoric with cutting-edge communication techniques. His expertise empowers individuals to deliver messages that resonate and foster genuine connections in a world overwhelmed by information.

DONATE LEGAL DEFENSE

OR SEND

TO CASH APP:$docnorm

ZELLE 3135103378

ALL WATCHED OVER BY MACHINES OF LOVING GRACE

BE SURE TO DONATE TO THE MARK IBSEN GOFUNDME DEFENSE FUND, WHERE THE SON ALWAYS RISES!!!

Tree of knowledge system - Wikipedia
OUR KNOWLEDGE WILL NEVER BE SUPPRESSED

FOR NOW, YOU ARE WITHIN

YOUAREWITHINTHENORMS.COM, BENJAMIN CLEMENTINE “THE NEMESIS” LONDON ENGLAN 2015

THE NORMS

REFERENCES:

AI, Pain Medication, and the Opioid Crisis: A Study Guide

I. Key Concepts and Summary

This article from Marketplace Tech discusses the increasing use of artificial intelligence (AI) in monitoring and influencing the prescription of pain medication, particularly opioids. The goal is to combat the opioid crisis by identifying potential misuse and preventing overdoses. Tools like Narx Scores and algorithm-generated overdose risk ratings are used to assess patients’ risk based on their prescription history. These systems draw data from state-run Prescription Drug Monitoring Programs (PDMPs).

While these AI systems aim to reduce opioid-related harm, they also raise concerns about bias, accuracy, lack of transparency, and potential harm to patients with legitimate pain management needs. Some patients have reported being denied necessary medication or stigmatized due to their scores. Some doctors also report being unfairly targeted, even losing licenses. The article highlights the need for independent testing, transparency, and careful consideration of the ethical and practical implications of using AI in healthcare decision-making.

II. Quiz: Short Answer Questions

  1. What is a Narx Score, and what is it used for?
  2. What are Prescription Drug Monitoring Programs (PDMPs), and how are they used?
  3. According to the article, what are some potential benefits of using AI to monitor opioid prescriptions?
  4. What are some concerns or criticisms raised about the use of AI in opioid prescription monitoring?
  5. How might AI-driven prescription monitoring affect patients with chronic pain?
  6. What steps has the CDC taken to address the use of PDMP programs?
  7. Besides NarxCare, what other uses of AI in the opioid crisis are mentioned in the article?
  8. What does the American Medical Association (AMA) say about the use of unknown or unreviewed algorithms when prescribing pain medication?
  9. What data points are taken into consideration when Bamboo Health (formerly Appriss Health) generates an “Overdose Risk Score?”
  10. What steps does Qlarant take to identify questionable behavior among doctors prescribing controlled substances?

III. Quiz: Answer Key

  1. A Narx Score is a tool used to help medical providers review controlled substance prescriptions. It influences and can limit the prescribing of painkillers, similar to a credit score influencing the terms of a loan. Bamboo Health produces it on its NarxCare platform.
  2. Prescription Drug Monitoring Programs (PDMPs) are electronic databases used by states to track prescriptions for controlled substances. This data can be fed into platforms such as NarxCare to help medical professionals make decisions.
  3. Potential benefits include identifying patterns of potential problems involving patients and physicians, reducing opioid prescriptions, speeding up the development of addiction medications, and reducing harm from the opioid crisis.
  4. Concerns include bias, accuracy, lack of transparency, insufficient independent testing, potential for harm to patients, stigmatization, and unfair targeting of doctors.
  5. AI-driven prescription monitoring may lead to patients being denied necessary medication, stigmatized, undertreated for pain, or forced to seek medication from illicit sources.
  6. The CDC advises clinicians to consult PDMP data before prescribing pain medications but warns that “special attention should be paid to ensure that PDMP information is not used in a way that is harmful to patients.”
  7. AI is also being used to predict opioid overdose deaths in communities via social media posts and to speed up the development of medications for opioid addiction.
  8. The AMA states that “These unknown and unreviewed algorithms have resulted in physicians having their prescribing privileges immediately suspended without due process or review by a state licensing board — often harming patients in pain because of delays and denials of care.”
  9. NarxCare’s algorithm-generated “Overdose Risk Score” draws on a patient’s medication information from PDMPs — such as the number of doctors writing prescriptions, the number of pharmacies used, and drug dosage.
  10. Qlarant algorithms can “analyze a wide variety of data sources,” including court records, insurance claims, drug monitoring data, property records, and incarceration data to flag providers.

IV. Essay Questions

  1. Discuss the ethical considerations surrounding the use of AI in healthcare decision-making, specifically in the context of opioid prescription monitoring.
  2. Analyze the potential benefits and drawbacks of using AI to combat the opioid crisis, considering both the perspectives of healthcare providers and patients.
  3. Evaluate the role of transparency and independent testing in ensuring the responsible and effective use of AI in opioid prescription monitoring.
  4. How can the potential for bias in AI algorithms used for opioid prescription monitoring be mitigated?
  5. What are the implications of using proprietary algorithms in healthcare, particularly regarding due process and patient rights?

V. Glossary of Key Terms

  • Algorithm: A set of rules or instructions that a computer follows to perform a specific task or solve a problem.
  • Artificial Intelligence (AI): The theory and development of computer systems able to perform tasks that normally require human intelligence, such as visual perception, speech recognition, decision-making, and translation between languages.
  • Bias (in AI): Systemic errors in an algorithm that lead to unfair or inaccurate outcomes for certain groups or individuals.
  • Chronic Pain: Persistent or recurring pain that lasts longer than the typical healing time for an injury or illness.
  • Controlled Substance: A drug or chemical whose manufacture, possession, or use is regulated by the government due to its potential for abuse or addiction.
  • Data Privacy: The right of individuals to control how their personal data is collected, used, and shared.
  • NarxCare: A suite of tools developed by Bamboo Health (formerly Appriss Health) that generates risk scores based on a patient’s prescription history.
  • Narx Score: A numerical score generated by NarxCare that is intended to indicate a patient’s risk of prescription drug misuse.
  • Opioid: A class of drugs used to reduce pain. Opioids can be highly addictive.
  • Opioid Crisis: A public health crisis in the United States characterized by a significant increase in opioid use, misuse, addiction, and overdose deaths.
  • Overdose Risk Score: An algorithm-generated score, part of NarxCare, drawing on a patient’s medication information from PDMPs to help medical providers assess a patient’s risk of opioid overdose.
  • Prescription Drug Monitoring Program (PDMP): A state-run electronic database that tracks the prescribing and dispensing of controlled substances.
  • Transparency (in AI): The extent to which the workings of an AI system are understandable and open to scrutiny.
Coley Reynolds - Lawyer in Philadelphia, PA - Avvo
Coley Reynolds – Lawyer in Philadelphia, PA – Avvo

Motion for Franks Hearing: Coley Reynolds Case

1 source

Neil K. Anand, a medical doctor, is contesting a search warrant and seeking to suppress evidence in the Eastern District of Pennsylvania. His legal counsel argues that evidence relating to Patient F.H. was obtained via a warrantless search. They also argue that the August 2019 search warrant for DrChrono records was defective because key information was omitted from the warrant affidavit, which negated probable cause. Anand’s team asserts that this omission violated his Fourth Amendment rights. The defense is requesting a Franks hearing to challenge the validity of the warrant based on these alleged omissions, arguing that the warrant would not have been issued if the magistrate had been aware of the omitted information. He believes the illegal intrusion into patient medical records warrants the suppression of evidence.

Anand Healthcare Fraud Case: Motion to Suppress & Franks Hearing

Briefing Document: United States v. Neil K. Anand – Motion to Suppress and Request for Franks Hearing

Date: October Feb 15, 2025

Subject: Review of Defendant Neil K. Anand’s Motion to Suppress Evidence and Request for a Franks Hearing related to an investigation of healthcare and wire fraud related to prescribing controlled substances.

1. Executive Summary:

This briefing concerns Dr. Neil K. Anand’s motion to suppress evidence obtained (1) related to Patient F.H. and (2) through a search warrant executed on August 20, 2019, targeting records stored on DrChrono. Dr. Anand also requests a Franks hearing, alleging that law enforcement omitted crucial information from the search warrant affidavit, which would have negated probable cause. The core argument is that evidence was obtained through a warrantless search (F.H.) and a defective warrant (DrChrono), violating Dr. Anand’s Fourth Amendment rights.

2. Background:

  • Dr. Anand is accused of unlawfully prescribing controlled substances and billing for unnecessary services. The government’s investigation included interviews with patients and employees, and the execution of search warrants.
  • The investigation centers around potential violations of 18 U.S.C. § 1347 (health care fraud), 18 U.S.C. § 1343 (wire fraud), and 21 U.S.C. § 841(a)(1) and 846 (conspiracy to distribute controlled substances), among other statutes.
  • The affidavit in support of the search warrant describes a scheme where Dr. Anand allegedly provided patients with unnecessary medications (“Goody Bags”) in exchange for prescriptions for controlled substances, and billed insurance for these unnecessary medications.
  • The affidavit details interviews with former employees and patients who describe the “Goody Bag” scheme, the use of “Foreign Graduates” to see patients and prescribe medications, and the practice of pre-signing prescriptions.
  • The affidavit outlines specific instances of high-dollar amounts billed to Medicare, OPM, and IBC for “Goody Bag” medications prescribed to multiple patients (Patients 1-7).
  • The government sought records from DrChrono under 18 U.S.C. §§ 2703(a), 2703(b)(1)(A), and 2703(c)(1)(A).

3. Key Arguments in the Motion to Suppress:

  • Standing: Dr. Anand argues that he has a reasonable expectation of privacy in the DrChrono records and therefore has standing to challenge the warrant. The motion cites cases like United States v. Gosy, United States v. Newman, and United States v. Pompy to support the argument that physicians have a legitimate expectation of privacy in patient medical records, especially when they own and operate the practice, maintain the records, and the records are password protected. “Dr. Anand owned and operated the practices at issue here…The records, stored on DrChrono, were password protected and only he and his staff had the password…Dr. Anand, while not the only person who enters information into DrChrono, is the sole person responsibility with maintaining the records.”
  • Evidence of F.H. Suppression: The motion claims that evidence related to Patient F.H. should be suppressed because law enforcement had prior knowledge of F.H.’s medical treatment before the May 7, 2019, interview. The suggestion here is that information was gathered improperly before the interview, tainting the evidence.
  • Defective Search Warrant (DrChrono): The motion argues that the August 20, 2019, search warrant for DrChrono records should be suppressed because law enforcement omitted information about the circumstances with Patient F.H. from the affidavit, which, if included, would have negated a finding of probable cause. “The confidential medical records seized from DrChrono with the August 20, 2019 search warrant should be suppressed as law enforcement omitted from the affidavit the illegal activity related to the interview of F.H.”
  • Fourth Amendment Violation & Exclusionary Rule: The motion argues that the Fourth Amendment was violated through the warrantless search. It emphasizes that law enforcement’s deliberate disregard for Fourth Amendment rights necessitates the exclusion of evidence. “Here, law enforcement exhibited deliberate disregard for Dr. Anand’s Fourth Amendment rights by the warrantless search of private patient medical records before the issuance of a search warrant. The need to deter such egregious conduct in the future far outweighs the cost in this matter, and the Court must exclude the evidence and suppress the seized items as “fruit of the poisonous tree.”
  • Franks Hearing Request: Dr. Anand requests a Franks hearing to challenge the validity of the search warrant affidavit. The motion asserts that the omission of facts related to F.H. constitutes a reckless disregard for the truth. Citing United States v. Pavulak and Franks v. Delaware, the motion outlines the two-prong test for obtaining a Franks hearing: (1) a “substantial preliminary showing” that the affiant knowingly or recklessly included a false statement or omitted facts and (2) demonstration that the false statement or omitted facts are “necessary to the finding of probable cause.” The motion asserts that both prongs are met in this case.

4. Key Evidence and Allegations from the Government’s Affidavit (Challenged by the Motion):

  • “Goody Bags”: Allegations of dispensing unnecessary medications to patients in “Goody Bags” in exchange for controlled substance prescriptions.
  • Foreign Graduates: Use of unlicensed “Foreign Graduates” to provide medical advice and prescribe medications.
  • Pre-signed Prescriptions: Allegations of leaving pre-signed prescription pads for the “Foreign Graduates” to use.
  • Patient Interviews: Statements from multiple patients (Patients 1-7) detailing the “Goody Bag” scheme, unwanted medications, and the pressure to accept the bags to receive needed prescriptions.
  • Claims Data: Evidence of substantial Medicare, OPM, and IBC payments for “Goody Bag” medications. For example, the affidavit states: “Between November 1, 2015, and July 17, 2019, ANAND was paid approximately $4,080,167 by Medicare, OPM, and IBC for medically unnecessary Goody Bag medications.”

5. Legal Standards Cited:

  • Fourth Amendment: Protection against unreasonable searches and seizures.
  • Franks v. Delaware, 438 U.S. 154 (1978): Establishes the standard for challenging the veracity of a search warrant affidavit.
  • Exclusionary Rule: A remedy that prohibits the use of illegally obtained evidence in a criminal trial.
  • 18 U.S.C. §§ 2703(a), 2703(b)(1)(A), and 2703(c)(1)(A): Pertain to required disclosure of electronic communications to the government.

6. Potential Outcomes

  • The court could grant the motion to suppress, excluding some or all of the evidence obtained from the search of DrChrono and related to patient F.H..
  • The court could deny the motion to suppress, allowing the government to use the evidence at trial.
  • The court could grant a Franks hearing, which would allow Dr. Anand to challenge the veracity of the search warrant affidavit. If successful at the Franks hearing, the warrant could be invalidated, and the evidence suppressed.

7. Conclusion:

Dr. Anand’s motion hinges on the argument that his Fourth Amendment rights were violated by a defective search warrant and a warrantless search. The outcome of the motion and the Franks hearing request could significantly impact the government’s case.

Anand Case: Timeline, Characters, and “Goody Bag” Scheme

Leave a Reply